IGF-1 Peptide Hydrogel Delivers Stem Cells to Heal Acute Kidney Injury
A self-assembling peptide hydrogel incorporating the IGF-1C domain with D-amino acids improves stem cell survival and kidney repair in acute kidney injury.
Quick Facts
What This Study Found
An IGF-1C domain peptide hydrogel with D-amino acid stability enhancement improves MSC survival, engraftment, and therapeutic efficacy in acute kidney injury.
Key Numbers
IGF-1C domain; D-form peptide; β-sheet self-assembly; enhanced angiogenesis; kidney function recovery
How They Did This
Self-assembling peptide hydrogel synthesis, MSC encapsulation and delivery, acute kidney injury mouse/rat model, histological and functional kidney assessments.
Why This Research Matters
Stem cell therapy for kidney injury is limited by poor cell survival after transplantation. This peptide hydrogel solves that problem by creating a protective microenvironment.
The Bigger Picture
Bioactive peptide hydrogels that mimic growth factor signals while protecting transplanted cells could transform regenerative medicine across multiple organ systems.
What This Study Doesn't Tell Us
Animal study. Long-term fate of MSCs in hydrogel not assessed. Translation to human kidney injury treatment needs clinical validation.
Questions This Raises
- ?Does the hydrogel persist long enough for complete kidney repair?
- ?Could this approach work for chronic kidney disease?
- ?Is the IGF-1C signaling essential or is the structural support sufficient?
Trust & Context
- Key Stat:
- Improved survival MSCs delivered in IGF-1C peptide hydrogel showed enhanced engraftment and therapeutic efficacy in AKI
- Evidence Grade:
- Animal study with functional outcome data. Strong preclinical evidence for hydrogel-enhanced stem cell therapy.
- Study Age:
- Published in 2020. Peptide hydrogels for regenerative medicine continue to advance.
- Original Title:
- Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Consisting IGF-1C Domain and D-Form Peptide for Acute Kidney Injury Therapy.
- Published In:
- International journal of nanomedicine, 15, 4311-4324 (2020)
- Authors:
- Wang, Hongfeng, Shang, Yuna, Chen, Xiaoniao, Wang, Zhongyan, Zhu, Dashuai, Liu, Yue, Zhang, Chuyue, Chen, Pu, Wu, Jie, Wu, Lingling, Kong, Deling, Yang, Zhimou, Li, Zongjin, Chen, Xiangmei
- Database ID:
- RPEP-05190
Evidence Hierarchy
Frequently Asked Questions
Why do stem cells need a hydrogel for kidney repair?
When stem cells are injected into damaged tissue, most die quickly without a supportive environment. The peptide hydrogel acts like scaffolding that protects cells, keeps them in place, and provides growth factor signals (IGF-1C) that help them survive and repair the kidney.
What makes this hydrogel special?
It combines a bioactive IGF-1C peptide that mimics growth factor signaling with D-form amino acids that make it resistant to enzymatic breakdown. This provides both biological function and structural stability.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05190APA
Wang, Hongfeng; Shang, Yuna; Chen, Xiaoniao; Wang, Zhongyan; Zhu, Dashuai; Liu, Yue; Zhang, Chuyue; Chen, Pu; Wu, Jie; Wu, Lingling; Kong, Deling; Yang, Zhimou; Li, Zongjin; Chen, Xiangmei. (2020). Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Consisting IGF-1C Domain and D-Form Peptide for Acute Kidney Injury Therapy.. International journal of nanomedicine, 15, 4311-4324. https://doi.org/10.2147/IJN.S254635
MLA
Wang, Hongfeng, et al. "Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Consisting IGF-1C Domain and D-Form Peptide for Acute Kidney Injury Therapy.." International journal of nanomedicine, 2020. https://doi.org/10.2147/IJN.S254635
RethinkPeptides
RethinkPeptides Research Database. "Delivery of MSCs with a Hybrid β-Sheet Peptide Hydrogel Cons..." RPEP-05190. Retrieved from https://rethinkpeptides.com/research/wang-2020-delivery-of-mscs-with
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.